GlassScriptPhysician profile
Stefan P Gilthorpe
NPI 1245677145
$8,116.09
in general payments reported to CMS, 2019-2025
37 companies · $837 in 2025
The $837 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,359 · 2020: $367 · 2021: $486 · 2022: $1,595 · 2023: $2,149 · 2024: $323 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270 · Travel and Lodging: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.64 |
| Travel and Lodging | $1,039.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,238.07 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $1,975.90 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Spinal Simplicity, LLC | $862.11 | 2020-2022 | |
| Nevro Corp. | $537.65 | 2019-2024 | Senza |
| Abbott Laboratories | $421.86 | 2019-2021 | |
| Painteq LLC | $272.50 | 2022-2023 | Painteq |
| Averitas Pharma INC. | $186.01 | 2024-2025 | Qutenza |
| Medtronic USA, INC. | $160.12 | 2019 | |
| Stryker Corporation | $156.92 | 2025 | Optablate, Omnicurve |
| Tersera Therapeutics LLC | $128.14 | 2022-2024 | Prialt |
| Spr Therapeutics, INC | $108.57 | 2023-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $89.77 | 2023 | Evoke Scs |
| Valinor Pharma, LLC | $88.90 | 2025 | Movantik |
| Vertos Medical, INC. | $86.63 | 2022-2023 | Mild Device Kit |
| Relievant Medsystems, INC. | $72.35 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $61.51 | 2023 | Reactiv8 |
| Si-Bone, INC. | $59.03 | 2025 | |
| Nalu Medical, INC. | $58.24 | 2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $57.08 | 2025 | Vyrsa V1, Senza |
| Azurity Pharmaceuticals, INC. | $56.04 | 2023-2025 | Horizant, Horizant |
| Amgen INC. | $55.11 | 2021-2022 | |
| Abbvie INC. | $46.56 | 2024-2025 | |
| Lilly USA, LLC | $38.59 | 2019 | |
| Collegium Pharmaceutical, INC. | $34.70 | 2025 | Belbuca |
| Bioventus LLC | $32.83 | 2023 | Supartz Fx Sodium Hyaluronate, Durolane |
| Horizon Therapeutics Plc | $29.78 | 2021 | |
| Biodelivery Sciences International, INC. | $22.91 | 2019 | |
| Curonix LLC | $22.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $22.14 | 2025 | |
| Forte Bio-Pharma LLC | $22.03 | 2022 | |
| Allergan, INC. | $19.83 | 2021 | |
| Biotronik Nro, INC. | $19.59 | 2025 | |
| Ermi LLC | $16.71 | 2021 | |
| Fidia Pharma USA INC. | $15.84 | 2025 | Hymovis, Triluron |
| Depuy Synthes Sales INC. | $13.54 | 2023 | Orthovisc, Monovisc |
| Ibsa Pharma INC. | $13.50 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefan Gilthorpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.